Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-05-10 2:24 pm Unchanged | 13D | Cutera, Inc. CUTR | RTW INVESTMENTS LP | 1,846,596 9.3% | 0 (Unchanged) | View |
| 2023-05-05 09:14 am Purchase | 13D | Orchestra BioMed Holdings, Inc. OBIO | RTW INVESTMENTS LP | 5,620,645 15.7% | 502,133 (+9.81%) | View |
| 2023-04-12 9:29 pm Purchase | 13D | Cutera, Inc. CUTR | RTW INVESTMENTS LP | 1,846,596 9.3% | 47,921 (+2.66%) | View |
| 2023-04-05 4:31 pm Sale | 13D | Renovacor Inc. RCOR | RTW INVESTMENTS LP | 0 0% | -3,350,803 (Position Closed) | View |
| 2023-04-05 4:31 pm Purchase | 13D | Rocket Pharmaceuticals, Inc. RCKT | RTW INVESTMENTS LP | 18,188,457 23% | 559,890 (+3.18%) | View |
| 2023-02-14 10:29 am Sale | 13G | Clearside Biomedical, Inc. CLSD | RTW INVESTMENTS LP | 0 0% | -3,806,018 (Position Closed) | View |
| 2023-02-14 10:27 am Sale | 13G | Athira Pharma, Inc. ATHA | RTW INVESTMENTS LP | 0 0% | -1,906,557 (Position Closed) | View |
| 2023-02-14 10:24 am Sale | 13G | ASLAN Pharmaceuticals Limited ASLN | RTW INVESTMENTS LP | 0 0% | -16,250,000 (Position Closed) | View |
| 2023-02-14 10:22 am Sale | 13G | CytomX Therapeutics, Inc. CTMX | RTW INVESTMENTS LP | 0 0% | -6,029,700 (Position Closed) | View |
| 2023-02-14 10:20 am Sale | 13G | Adverum Biotechnologies, Inc. ADVM | RTW INVESTMENTS LP | 0 0% | -7,554,817 (Position Closed) | View |
| 2023-02-14 10:17 am Sale | 13G | BELLUS Health Inc. BLU | RTW INVESTMENTS LP | 0 0% | -5,968,017 (Position Closed) | View |
| 2023-02-14 10:15 am Sale | 13G | Aptevo Therapeutics Inc. APVO | RTW INVESTMENTS LP | 0 0% | -288,236 (Position Closed) | View |
| 2023-02-14 10:13 am Sale | 13G | ProQR Therapeutics N.V. PRQR | RTW INVESTMENTS LP | 0 0% | -7,027,725 (Position Closed) | View |
| 2023-02-14 10:12 am Sale | 13G | MacroGenics, Inc. MGNX | RTW INVESTMENTS LP | 0 0% | -3,975,554 (Position Closed) | View |
| 2023-02-14 10:11 am Sale | 13G | Vericel Corporation VCEL | RTW INVESTMENTS LP | 3,099,904 6.6% | -1,417,666 (-31.38%) | View |
| 2023-02-14 10:11 am Sale | 13G | IDEAYA Biosciences, Inc. IDYA | RTW INVESTMENTS LP | 0 0% | -2,520,076 (Position Closed) | View |
| 2023-02-14 10:10 am Purchase | 13G | Ultragenyx Pharmaceutical Inc. RARE | RTW INVESTMENTS LP | 3,966,915 5.7% | 3,966,915 (New Position) | View |
| 2023-02-14 10:10 am Sale | 13G | TELA Bio, Inc. TELA | RTW INVESTMENTS LP | 390,364 2% | -1,009,322 (-72.11%) | View |
| 2023-02-14 10:10 am Sale | 13G | Relmada Therapeutics, Inc. RLMD | RTW INVESTMENTS LP | 2,067,824 6.9% | -118,500 (-5.42%) | View |
| 2023-02-14 10:09 am Purchase | 13G | Mirati Therapeutics, Inc. MRTX | RTW INVESTMENTS LP | 3,643,114 6.3% | 3,643,114 (New Position) | View |